Skip to main content
Top
Published in: BMC Immunology 1/2003

Open Access 01-12-2003 | Research article

Interferon-α/β receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006

Authors: Atsushi Kato, Toshiki Homma, Jonathan Batchelor, Noriko Hashimoto, Shosuke Imai, Hiroshi Wakiguchi, Hirohisa Saito, Kenji Matsumoto

Published in: BMC Immunology | Issue 1/2003

Login to get access

Abstract

Background

Oligodeoxynucleotides containing unmethylated CpG motifs (CpG ODN) are known to exert a strong adjuvant effect on Th1 immune responses. Although several genes have been reported, no comprehensive study of the gene expression profiles in human cells after stimulation with CpG ODN has been reported.

Results

This study was designed to identify a CpG-inducible gene cluster that potentially predicts for the molecular mechanisms of clinical efficacy of CpG ODN, by determining mRNA expression in human PBMC after stimulation with CpG ODN. PBMCs were obtained from the peripheral blood of healthy volunteers and cultured in the presence or absence of CpG ODN 2006 for up to 24 hours. The mRNA expression profile was evaluated using a high-density oligonucleotide probe array, GeneChip®. Using hierarchical clustering-analysis, out of a total of 10,000 genes we identified a cluster containing 77 genes as having been up-regulated by CpG ODN. This cluster was further divided into two sub-clusters by means of time-kinetics. (1) Inflammatory cytokines such as IL-6 and GM-CSF were up-regulated predominantly 3 to 6 hours after stimulation with CpG ODN, presumably through activation of a transcription factor, NF-κB. (2) Interferon (IFN)-inducible anti-viral proteins, including IFIT1, OAS1 and Mx1, and Th1 chemoattractant IP-10, were up-regulated predominantly 6 to 24 hours after stimulation. Blocking with mAb against IFN-α/β receptor strongly inhibited the induction of these IFN-inducible genes by CpG ODN.

Conclusion

This study provides new information regarding the possible immunomodulatory effects of CpG ODN in vivo via an IFN-α/β receptor-mediated paracrine pathway.
Appendix
Available only for authorised users
Literature
1.
go back to reference Whittle HC, Lamb WH, Ryder RW: Trials of intradermal hepatitis B vaccines in Gambian children. Ann Trop Paediatr. 1987, 7: 6-9.PubMed Whittle HC, Lamb WH, Ryder RW: Trials of intradermal hepatitis B vaccines in Gambian children. Ann Trop Paediatr. 1987, 7: 6-9.PubMed
2.
go back to reference Uede T, Huff TF, Ishizaka K: Formation of IgE-binding factors by rat T lymphocytes. V. Effect of adjuvant for the priming immunization on the nature of IgE binding factors formed by antigenic stimulation. J Immunol. 1982, 129: 1384-90.PubMed Uede T, Huff TF, Ishizaka K: Formation of IgE-binding factors by rat T lymphocytes. V. Effect of adjuvant for the priming immunization on the nature of IgE binding factors formed by antigenic stimulation. J Immunol. 1982, 129: 1384-90.PubMed
3.
go back to reference Koh YI, Choi IS, Kim WY: BCG infection in allergen-presensitized rats suppresses Th2 immune response and prevents the development of allergic asthmatic reaction. J Clin Immunol. 2001, 21: 51-9. 10.1023/A:1006745116360.CrossRefPubMed Koh YI, Choi IS, Kim WY: BCG infection in allergen-presensitized rats suppresses Th2 immune response and prevents the development of allergic asthmatic reaction. J Clin Immunol. 2001, 21: 51-9. 10.1023/A:1006745116360.CrossRefPubMed
4.
go back to reference Tokunaga T, Yamamoto T, Yamamoto S: How BCG led to the discovery of immunostimulatory DNA. Jpn J Infect Dis. 1999, 52: 1-11.PubMed Tokunaga T, Yamamoto T, Yamamoto S: How BCG led to the discovery of immunostimulatory DNA. Jpn J Infect Dis. 1999, 52: 1-11.PubMed
5.
go back to reference Tokunaga T, Yamamoto H, Shimada S, Abe H, Fukuda T, Fujisawa Y, Furutani Y, Yano O, Kataoka T, Sudo T, et al.: Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst. 1984, 72: 955-62.PubMed Tokunaga T, Yamamoto H, Shimada S, Abe H, Fukuda T, Fujisawa Y, Furutani Y, Yano O, Kataoka T, Sudo T, et al.: Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst. 1984, 72: 955-62.PubMed
6.
go back to reference Hartmann G, Weeratna RD, Ballas ZK, Payette P, Blackwell S, Suparto I, Rasmussen WL, Waldschmidt M, Sajuthi D, Purcell RH, et al.: Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J Immunol. 2000, 164: 1617-24.CrossRefPubMed Hartmann G, Weeratna RD, Ballas ZK, Payette P, Blackwell S, Suparto I, Rasmussen WL, Waldschmidt M, Sajuthi D, Purcell RH, et al.: Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J Immunol. 2000, 164: 1617-24.CrossRefPubMed
7.
go back to reference Medzhitov R, Janeway CA: Innate immunity: the virtues of a nonclonal system of recognition. Cell. 1997, 91: 295-8.CrossRefPubMed Medzhitov R, Janeway CA: Innate immunity: the virtues of a nonclonal system of recognition. Cell. 1997, 91: 295-8.CrossRefPubMed
8.
go back to reference Krieg AM: The role of CpG motifs in innate immunity. Curr Opin Immunol. 2000, 12: 35-43. 10.1016/S0952-7915(99)00048-5.CrossRefPubMed Krieg AM: The role of CpG motifs in innate immunity. Curr Opin Immunol. 2000, 12: 35-43. 10.1016/S0952-7915(99)00048-5.CrossRefPubMed
9.
go back to reference Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF: A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A. 1998, 95: 588-93. 10.1073/pnas.95.2.588.PubMedCentralCrossRefPubMed Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF: A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A. 1998, 95: 588-93. 10.1073/pnas.95.2.588.PubMedCentralCrossRefPubMed
10.
go back to reference Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA: The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 1996, 86: 973-83.CrossRefPubMed Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA: The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 1996, 86: 973-83.CrossRefPubMed
11.
go back to reference Akira S, Takeda K, Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001, 2: 675-80. 10.1038/90609.CrossRefPubMed Akira S, Takeda K, Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001, 2: 675-80. 10.1038/90609.CrossRefPubMed
12.
go back to reference Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, et al.: A Toll-like receptor recognizes bacterial DNA. Nature. 2000, 408: 740-5. 10.1038/35047123.CrossRefPubMed Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, et al.: A Toll-like receptor recognizes bacterial DNA. Nature. 2000, 408: 740-5. 10.1038/35047123.CrossRefPubMed
13.
go back to reference Takeshita F, Leifer CA, Gursel I, Ishii KJ, Takeshita S, Gursel M, Klinman DM: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol. 2001, 167: 3555-8.CrossRefPubMed Takeshita F, Leifer CA, Gursel I, Ishii KJ, Takeshita S, Gursel M, Klinman DM: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol. 2001, 167: 3555-8.CrossRefPubMed
14.
go back to reference Krieg AM: CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002, 20: 709-60. 10.1146/annurev.immunol.20.100301.064842.CrossRefPubMed Krieg AM: CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002, 20: 709-60. 10.1146/annurev.immunol.20.100301.064842.CrossRefPubMed
15.
go back to reference Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas ZK, Endres S, Krieg AM, Hartmann G: Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol. 2001, 31: 2154-63. 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U.CrossRefPubMed Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas ZK, Endres S, Krieg AM, Hartmann G: Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol. 2001, 31: 2154-63. 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U.CrossRefPubMed
16.
go back to reference Gursel M, Verthelyi D, Gursel I, Ishii KJ, Klinman DM: Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J Leukoc Biol. 2002, 71: 813-20.PubMed Gursel M, Verthelyi D, Gursel I, Ishii KJ, Klinman DM: Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J Leukoc Biol. 2002, 71: 813-20.PubMed
17.
go back to reference Zdilar D, Franco-Bronson K, Buchler N, Locala JA, Younossi ZM: Hepatitis C, interferon alfa, and depression. Hepatology. 2000, 31: 1207-11.CrossRefPubMed Zdilar D, Franco-Bronson K, Buchler N, Locala JA, Younossi ZM: Hepatitis C, interferon alfa, and depression. Hepatology. 2000, 31: 1207-11.CrossRefPubMed
18.
go back to reference Der SD, Zhou A, Williams BR, Silverman RH: Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A. 1998, 95: 15623-8. 10.1073/pnas.95.26.15623.PubMedCentralCrossRefPubMed Der SD, Zhou A, Williams BR, Silverman RH: Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A. 1998, 95: 15623-8. 10.1073/pnas.95.26.15623.PubMedCentralCrossRefPubMed
19.
go back to reference Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G: Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol. 2002, 168: 4531-7.CrossRefPubMed Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G: Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol. 2002, 168: 4531-7.CrossRefPubMed
20.
go back to reference Blackwell SE, Krieg AM: CpG-A-Induced Monocyte IFN-gamma-Inducible Protein-10 Production Is Regulated by Plasmacytoid Dendritic Cell-Derived IFN-alpha. J Immunol. 2003, 170: 4061-8.CrossRefPubMed Blackwell SE, Krieg AM: CpG-A-Induced Monocyte IFN-gamma-Inducible Protein-10 Production Is Regulated by Plasmacytoid Dendritic Cell-Derived IFN-alpha. J Immunol. 2003, 170: 4061-8.CrossRefPubMed
21.
go back to reference Munoz C, Pascual-Salcedo D, Castellanos MC, Alfranca A, Aragones J, Vara A, Redondo MJ, de Landazuri MO: Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kappa B and AP-1 transcription factors activity. Blood. 1996, 88: 3482-90.PubMed Munoz C, Pascual-Salcedo D, Castellanos MC, Alfranca A, Aragones J, Vara A, Redondo MJ, de Landazuri MO: Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kappa B and AP-1 transcription factors activity. Blood. 1996, 88: 3482-90.PubMed
22.
go back to reference Ohshima Y, Yang LP, Avice MN, Kurimoto M, Nakajima T, Sergerie M, Demeure CE, Sarfati M, Delespesse G: Naive human CD4+ T cells are a major source of lymphotoxin alpha. J Immunol. 1999, 162: 3790-4.PubMed Ohshima Y, Yang LP, Avice MN, Kurimoto M, Nakajima T, Sergerie M, Demeure CE, Sarfati M, Delespesse G: Naive human CD4+ T cells are a major source of lymphotoxin alpha. J Immunol. 1999, 162: 3790-4.PubMed
23.
go back to reference Shan X, Bourdeau A, Rhoton A, Wells DE, Cohen EH, Landgraf BE, Palfree RG: Characterization and mapping to human chromosome 8q24.3 of Ly-6-related gene 9804 encoding an apparent homologue of mouse TSA-1. J Immunol. 1998, 160: 197-208.PubMed Shan X, Bourdeau A, Rhoton A, Wells DE, Cohen EH, Landgraf BE, Palfree RG: Characterization and mapping to human chromosome 8q24.3 of Ly-6-related gene 9804 encoding an apparent homologue of mouse TSA-1. J Immunol. 1998, 160: 197-208.PubMed
24.
go back to reference Grotzinger T, Jensen K, Will H: The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-gamma activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility. J Biol Chem. 1996, 271: 25253-60. 10.1074/jbc.271.41.25253.CrossRefPubMed Grotzinger T, Jensen K, Will H: The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-gamma activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility. J Biol Chem. 1996, 271: 25253-60. 10.1074/jbc.271.41.25253.CrossRefPubMed
25.
go back to reference Sciavolino PJ, Vilcek J: Regulation of metallothionein gene expression by TNF-alpha and IFN-beta in human fibroblasts. Cytokine. 1995, 7: 242-50. 10.1006/cyto.1995.0028.CrossRefPubMed Sciavolino PJ, Vilcek J: Regulation of metallothionein gene expression by TNF-alpha and IFN-beta in human fibroblasts. Cytokine. 1995, 7: 242-50. 10.1006/cyto.1995.0028.CrossRefPubMed
26.
go back to reference Silverman RH, Halloum A, Zhou A, Dong B, Al-Zoghaibi F, Kushner D, Zhou Q, Zhao J, Wiedmer T, Sims PJ: Suppression of ovarian carcinoma cell growth in vivo by the interferon-inducible plasma membrane protein, phospholipid scramblase 1. Cancer Res. 2002, 62: 397-402.PubMed Silverman RH, Halloum A, Zhou A, Dong B, Al-Zoghaibi F, Kushner D, Zhou Q, Zhao J, Wiedmer T, Sims PJ: Suppression of ovarian carcinoma cell growth in vivo by the interferon-inducible plasma membrane protein, phospholipid scramblase 1. Cancer Res. 2002, 62: 397-402.PubMed
27.
go back to reference Sedger LM, Shows DM, Blanton RA, Peschon JJ, Goodwin RG, Cosman D, Wiley SR: IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J Immunol. 1999, 163: 920-6.PubMed Sedger LM, Shows DM, Blanton RA, Peschon JJ, Goodwin RG, Cosman D, Wiley SR: IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J Immunol. 1999, 163: 920-6.PubMed
28.
go back to reference Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K, Yagita H: Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs. J Exp Med. 1999, 189: 1451-60. 10.1084/jem.189.9.1451.PubMedCentralCrossRefPubMed Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K, Yagita H: Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs. J Exp Med. 1999, 189: 1451-60. 10.1084/jem.189.9.1451.PubMedCentralCrossRefPubMed
29.
go back to reference Brinkmann V, Geiger T, Alkan S, Heusser CH: Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med. 1993, 178: 1655-63.CrossRefPubMed Brinkmann V, Geiger T, Alkan S, Heusser CH: Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med. 1993, 178: 1655-63.CrossRefPubMed
30.
go back to reference Hunter CA, Gabriel KE, Radzanowski T, Neyer LE, Remington JS: Type I interferons enhance production of IFN-gamma by NK cells. Immunol Lett. 1997, 59: 1-5. 10.1016/S0165-2478(97)00091-6.CrossRefPubMed Hunter CA, Gabriel KE, Radzanowski T, Neyer LE, Remington JS: Type I interferons enhance production of IFN-gamma by NK cells. Immunol Lett. 1997, 59: 1-5. 10.1016/S0165-2478(97)00091-6.CrossRefPubMed
31.
go back to reference Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, et al.: Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 2000, 13: 539-48.CrossRefPubMed Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, et al.: Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 2000, 13: 539-48.CrossRefPubMed
32.
go back to reference Le Bon A, Tough DF: Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol. 2002, 14: 432-6. 10.1016/S0952-7915(02)00354-0.CrossRefPubMed Le Bon A, Tough DF: Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol. 2002, 14: 432-6. 10.1016/S0952-7915(02)00354-0.CrossRefPubMed
33.
go back to reference Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ: The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999, 284: 1835-7. 10.1126/science.284.5421.1835.CrossRefPubMed Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ: The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999, 284: 1835-7. 10.1126/science.284.5421.1835.CrossRefPubMed
34.
go back to reference Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, Colonna M: Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999, 5: 919-23. 10.1038/11360.CrossRefPubMed Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, Colonna M: Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999, 5: 919-23. 10.1038/11360.CrossRefPubMed
35.
go back to reference Kerkmann M, Rothenfusser S, Hornung V, Towarowski A, Wagner M, Sarris A, Giese T, Endres S, Hartmann G: Activation with CpG-A and CpG-B Oligonucleotides Reveals Two Distinct Regulatory Pathways of Type I IFN Synthesis in Human Plasmacytoid Dendritic Cells. J Immunol. 2003, 170: 4465-74.CrossRefPubMed Kerkmann M, Rothenfusser S, Hornung V, Towarowski A, Wagner M, Sarris A, Giese T, Endres S, Hartmann G: Activation with CpG-A and CpG-B Oligonucleotides Reveals Two Distinct Regulatory Pathways of Type I IFN Synthesis in Human Plasmacytoid Dendritic Cells. J Immunol. 2003, 170: 4465-74.CrossRefPubMed
36.
37.
go back to reference Guo J, Hui DJ, Merrick WC, Sen GC: A new pathway of translational regulation mediated by eukaryotic initiation factor 3. Embo J. 2000, 19: 6891-9. 10.1093/emboj/19.24.6891.PubMedCentralCrossRefPubMed Guo J, Hui DJ, Merrick WC, Sen GC: A new pathway of translational regulation mediated by eukaryotic initiation factor 3. Embo J. 2000, 19: 6891-9. 10.1093/emboj/19.24.6891.PubMedCentralCrossRefPubMed
38.
go back to reference Diaz-Guerra M, Rivas C, Esteban M: Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology. 1997, 227: 220-8. 10.1006/viro.1996.8294.CrossRefPubMed Diaz-Guerra M, Rivas C, Esteban M: Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology. 1997, 227: 220-8. 10.1006/viro.1996.8294.CrossRefPubMed
39.
go back to reference Ponten A, Sick C, Weeber M, Haller O, Kochs G: Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity. J Virol. 1997, 71: 2591-9.PubMedCentralPubMed Ponten A, Sick C, Weeber M, Haller O, Kochs G: Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity. J Virol. 1997, 71: 2591-9.PubMedCentralPubMed
40.
go back to reference Malakhov MP, Malakhova OA, Kim KI, Ritchie KJ, Zhang DE: UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem. 2002, 277: 9976-81. 10.1074/jbc.M109078200.CrossRefPubMed Malakhov MP, Malakhova OA, Kim KI, Ritchie KJ, Zhang DE: UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem. 2002, 277: 9976-81. 10.1074/jbc.M109078200.CrossRefPubMed
41.
go back to reference Park Y, Chang YS, Lee SW, Cho SY, Kim YK, Min KU, Kim YY, Cho SH, Sung YC: The enhanced effect of a hexameric deoxyriboguanosine run conjugation to CpG oligodeoxynucleotides on protection against allergic asthma. J Allergy Clin Immunol. 2001, 108: 570-6. 10.1067/mai.2001.118517.CrossRefPubMed Park Y, Chang YS, Lee SW, Cho SY, Kim YK, Min KU, Kim YY, Cho SH, Sung YC: The enhanced effect of a hexameric deoxyriboguanosine run conjugation to CpG oligodeoxynucleotides on protection against allergic asthma. J Allergy Clin Immunol. 2001, 108: 570-6. 10.1067/mai.2001.118517.CrossRefPubMed
42.
go back to reference Marshall JD, Abtahi S, Eiden JJ, Tuck S, Milley R, Haycock F, Reid MJ, Kagey-Sobotka A, Creticos PS, Lichtenstein LM, et al.: Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. J Allergy Clin Immunol. 2001, 108: 191-7. 10.1067/mai.2001.116984.CrossRefPubMed Marshall JD, Abtahi S, Eiden JJ, Tuck S, Milley R, Haycock F, Reid MJ, Kagey-Sobotka A, Creticos PS, Lichtenstein LM, et al.: Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. J Allergy Clin Immunol. 2001, 108: 191-7. 10.1067/mai.2001.116984.CrossRefPubMed
43.
go back to reference Shirota H, Sano K, Hirasawa N, Terui T, Ohuchi K, Hattori T, Tamura G: B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12. J Immunol. 2002, 169: 787-94.CrossRefPubMed Shirota H, Sano K, Hirasawa N, Terui T, Ohuchi K, Hattori T, Tamura G: B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12. J Immunol. 2002, 169: 787-94.CrossRefPubMed
44.
go back to reference Santeliz JV, Van Nest G, Traquina P, Larsen E, Wills-Karp M: Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immunol. 2002, 109: 455-62. 10.1067/mai.2002.122156.CrossRefPubMed Santeliz JV, Van Nest G, Traquina P, Larsen E, Wills-Karp M: Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immunol. 2002, 109: 455-62. 10.1067/mai.2002.122156.CrossRefPubMed
45.
go back to reference Farrar JD, Murphy KM: Type I interferons and T helper development. Immunol Today. 2000, 21: 484-9. 10.1016/S0167-5699(00)01710-2.CrossRefPubMed Farrar JD, Murphy KM: Type I interferons and T helper development. Immunol Today. 2000, 21: 484-9. 10.1016/S0167-5699(00)01710-2.CrossRefPubMed
46.
go back to reference Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R, Giese T, Engelmann H, Endres S, Krieg AM, et al.: Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol. 2001, 31: 3026-37. 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H.CrossRefPubMed Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R, Giese T, Engelmann H, Endres S, Krieg AM, et al.: Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol. 2001, 31: 3026-37. 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H.CrossRefPubMed
47.
go back to reference Loetscher M, Loetscher P, Brass N, Meese E, Moser B: Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur J Immunol. 1998, 28: 3696-705. 10.1002/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.3.CO;2-N.CrossRefPubMed Loetscher M, Loetscher P, Brass N, Meese E, Moser B: Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur J Immunol. 1998, 28: 3696-705. 10.1002/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.3.CO;2-N.CrossRefPubMed
48.
go back to reference Weng Y, Siciliano SJ, Waldburger KE, Sirotina-Meisher A, Staruch MJ, Daugherty BL, Gould SL, Springer MS, DeMartino JA: Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem. 1998, 273: 18288-91. 10.1074/jbc.273.29.18288.CrossRefPubMed Weng Y, Siciliano SJ, Waldburger KE, Sirotina-Meisher A, Staruch MJ, Daugherty BL, Gould SL, Springer MS, DeMartino JA: Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem. 1998, 273: 18288-91. 10.1074/jbc.273.29.18288.CrossRefPubMed
49.
go back to reference Loetscher P, Pellegrino A, Gong JH, Mattioli I, Loetscher M, Bardi G, Baggiolini M, Clark-Lewis I: The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem. 2001, 276: 2986-91. 10.1074/jbc.M005652200.CrossRefPubMed Loetscher P, Pellegrino A, Gong JH, Mattioli I, Loetscher M, Bardi G, Baggiolini M, Clark-Lewis I: The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem. 2001, 276: 2986-91. 10.1074/jbc.M005652200.CrossRefPubMed
Metadata
Title
Interferon-α/β receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006
Authors
Atsushi Kato
Toshiki Homma
Jonathan Batchelor
Noriko Hashimoto
Shosuke Imai
Hiroshi Wakiguchi
Hirohisa Saito
Kenji Matsumoto
Publication date
01-12-2003
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2003
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-4-8

Other articles of this Issue 1/2003

BMC Immunology 1/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine